Targeted radiation attack on brain tumors shows promise in early trial
NCT ID NCT07003139
First seen Nov 18, 2025 · Last updated Apr 28, 2026 · Updated 16 times
Summary
This study tests a precise radiation treatment called boron neutron capture therapy (BNCT) for people with aggressive brain tumors. It uses a special boron compound (B10 L-BPA) that collects in tumor cells, then a neutron beam activates it to destroy those cells while sparing healthy tissue. The trial will enroll 10 adults with grade 3 or 4 brain tumors to check safety and whether tumors shrink or stop growing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT BRAIN TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China Medical University Hospital
RECRUITINGTaichung, 40447, Taiwan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
China Medical University Hsinchu Hospital
NOT_YET_RECRUITINGHsinchu, 302, Taiwan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.